Department of Pathology, University of Washington, Seattle, Washington, USA.
Victorian Clinical Genetics Services, Murdoch Children's Research Institute, Melbourne, Victoria, Australia.
Genet Med. 2018 Apr;20(4):411-419. doi: 10.1038/gim.2017.115. Epub 2017 Aug 17.
PurposeOsteogenesis imperfecta (OI) is a heritable skeletal dysplasia. Dominant pathogenic variants in COL1A1 and COL1A2 explain the majority of OI cases. At least 15 additional genes have been identified, but those still do not account for all OI phenotypes that present. We sought the genetic cause of mild and lethal OI phenotypes in an unsolved family.MethodsWe performed exome sequencing on seven members of the family, both affected and unaffected.ResultsWe identified a variant in cyclic AMP responsive element binding protein 3-like 1 (CREB3L1) in a consanguineous family. The variant caused a prenatal/perinatal lethal OI in homozygotes, similar to that seen in OI type II as a result of mutations in type I collagen genes, and a mild phenotype (fractures, blue sclerae) in multiple heterozygous family members. CREB3L1 encodes old astrocyte specifically induced substance (OASIS), an endoplasmic reticulum stress transducer. The variant disrupts a DNA-binding site and prevents OASIS from acting on its transcriptional targets including SEC24D, which encodes a component of the coat protein II complex.ConclusionThis report confirms that CREB3L1 is an OI-related gene and suggests the pathogenic mechanism of CREB3L1-associated OI involves the altered regulation of proteins involved in cellular secretion.
目的成骨不全症(OI)是一种遗传性骨骼发育不良。COL1A1 和 COL1A2 中的显性致病变异解释了大多数 OI 病例的原因。至少已经确定了 15 个其他基因,但这些基因仍然不能解释所有呈现的 OI 表型。我们试图在一个未解决的家庭中寻找轻度和致死性 OI 表型的遗传原因。
方法我们对该家庭的 7 名受影响和未受影响的成员进行了外显子组测序。
结果我们在一个近亲家庭中发现了环磷酸腺苷反应元件结合蛋白 3 样 1(CREB3L1)的变异。该变异导致纯合子发生产前/围产期致死性 OI,类似于由于 I 型胶原基因突变引起的 OI 类型 II,以及多个杂合子家庭成员的轻度表型(骨折、蓝色巩膜)。CREB3L1 编码老神经胶质细胞特异性诱导物质(OASIS),一种内质网应激转导物。该变异破坏了一个 DNA 结合位点,并阻止 OASIS 对其转录靶标(包括 SEC24D)发挥作用,SEC24D 编码 II 型衣壳蛋白复合物的组成部分。
结论本报告证实 CREB3L1 是一种 OI 相关基因,并表明 CREB3L1 相关 OI 的致病机制涉及参与细胞分泌的蛋白质的改变调节。